The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -37.86%-124.7K | 6.51%-136.2K | -52.15%-123.56K | -156.39%-393.3K | -337.14%-75.95K | -239.75%-90.46K | -33.16%-145.68K | -15.28%-81.21K | -7.32%-153.4K | 57.38%-17.37K |
Net income from continuing operations | -42.50%-195.07K | 47.45%-55.32K | -547.55%-328.65K | -24.21%-495.88K | -2.05%-202.95K | -90.99%-136.9K | 18.18%-105.28K | 22.27%-50.75K | 28.60%-399.22K | 78.51%-198.87K |
Operating gains losses | 1,155.84%155.95K | 52.97%-6K | 2,502.35%22.15K | -136.89%-14.9K | -43.47%-15.41K | -62.42%12.42K | -170.59%-12.76K | 391.91%851 | 31.93%40.39K | -1,199.08%-10.74K |
Unrealized gains and losses of investment securities | ---- | --0 | --142.63K | -52.72%59.72K | ---- | ---- | --0 | --0 | -58.86%126.32K | ---- |
Other non cashItems | 866.59%45.34K | ---88.87K | ---20.98K | -519.55%-69.29K | -672.83%-39.55K | -278.78%-5.91K | ---- | ---- | 222.17%16.52K | --6.91K |
Change In working capital | -70.67%11.71K | 467.28%14K | 295.78%61.3K | 103.00%127.06K | 107.17%122.25K | 359.13%39.94K | 25.46%-3.81K | -271.41%-31.31K | -32.03%62.59K | 17.04%59.01K |
-Change in payables and accrued expense | -70.67%11.71K | 467.28%14K | 295.78%61.3K | 103.00%127.06K | 107.17%122.25K | 359.13%39.94K | 25.46%-3.81K | -271.41%-31.31K | -32.03%62.59K | 17.04%59.01K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -37.86%-124.7K | 6.51%-136.2K | -52.15%-123.56K | -156.39%-393.3K | -337.14%-75.95K | -239.75%-90.46K | -33.16%-145.68K | -15.28%-81.21K | -7.32%-153.4K | 57.38%-17.37K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Cash from discontinued investing activities | ||||||||||
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -253.61%-153.21K | 6.34%103.37K | 21.22%156.07K | 348.11%393.76K | 289.38%68.07K | 285.32%99.74K | 118.41%97.21K | 189.28%128.75K | -33.79%87.87K | -72.18%17.48K |
Net issuance payments of debt | -253.61%-153.21K | 6.34%103.37K | 21.22%156.07K | 348.11%393.76K | 289.38%68.07K | 285.32%99.74K | 118.41%97.21K | 189.28%128.75K | -33.79%87.87K | -72.18%17.48K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -253.61%-153.21K | 6.34%103.37K | 21.22%156.07K | 348.11%393.76K | 289.38%68.07K | 285.32%99.74K | 118.41%97.21K | 189.28%128.75K | -33.79%87.87K | -72.18%17.48K |
Net cash flow | ||||||||||
Beginning cash position | 16.49%7.61K | -26.47%40.44K | 6.24%7.94K | -89.77%7.47K | 114.78%15.81K | -19.37%6.53K | -24.64%55.01K | -89.77%7.47K | -12.29%73K | -85.54%7.36K |
Current changes in cash | 47.99%13.73K | 32.26%-32.83K | -31.62%32.51K | 100.71%466 | -7,323.85%-7.87K | 1,351.96%9.28K | 25.30%-48.47K | 283.24%47.54K | -540.84%-65.53K | -99.51%109 |
End cash Position | 34.97%21.34K | 16.49%7.61K | -26.47%40.44K | 6.24%7.94K | 6.24%7.94K | 114.78%15.81K | -19.37%6.53K | 16.90%55.01K | -89.77%7.47K | -89.77%7.47K |
Free cash from | -37.86%-124.7K | 6.51%-136.2K | -52.15%-123.56K | -156.39%-393.3K | -337.14%-75.95K | -239.75%-90.46K | -33.16%-145.68K | -15.28%-81.21K | -7.32%-153.4K | 57.38%-17.37K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.